Our analysis revealed a significant decrease in ALDOC expression was found in patients with WHO stage II and III low-grade glioma (LGG) as well as WHO stage IV glioblastoma (GBM) compared with nontumor samples (Fig. 1A). The gene discussed is ALDOC; the disease is glioblastoma.